Latest News about AMGN
Recent news which mentions AMGN
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2022
From Benzinga
2 Top Healthcare Stocks to Buy for the Long Haul
October 18, 2022
From Motley Fool
Replimune Gets 33% Price Target Bump Ahead Of Upcoming Readouts. Analyst Lists The Catalysts
October 14, 2022
From Benzinga
4 Biotech Stocks With Huge Incoming Catalysts
October 12, 2022
From Motley Fool
A Congressman Just Sold JPMorgan Stock Ahead Of Earnings: See Two Dividend Stocks He Is Also Trading
October 11, 2022
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
From Benzinga
Apple To $155? Plus Morgan Stanley Cuts Price Target On Zoom Video
October 11, 2022
From Benzinga
US Buys $290M Anti-Radiation Drugs After Putin Ups Nuclear Threats
October 09, 2022
Tickers
AMGN
From Benzinga
7 Value Stocks That Are Too Cheap to Ignore
October 09, 2022
From InvestorPlace
2 Healthcare Stocks That Could Help Make You a Fortune
October 08, 2022
From Motley Fool
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today
October 06, 2022
Tickers
AMGN
From Benzinga
The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint — It's Very Short
October 03, 2022
From Benzinga
Could This Biosimilar Drug Candidate Be a Hit for Novartis?
October 03, 2022
From Motley Fool
3 Biotech Stocks to Buy and Hold for the Next 10 Years
September 28, 2022
From Motley Fool
Warning! A Housing Market Crash Will Tank These 3 Stocks.
September 27, 2022
Tags
KBH
RDFN
NYSE:IT,NASDAQ:AMGN,NYSE:LMND,NYSE:RKT,NASDAQ:OPEN,NASDAQ:Z,NYSE:OPAD,NYSE:WFC,NASDAQ:RDFN,NYSE:KBH
From InvestorPlace
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
September 27, 2022
From InvestorPlace
From Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today
September 21, 2022
Tickers
AMGN
From Benzinga
Take-Two Gets Beat Down After Leak of Its Popular Grand Theft Auto VI
September 19, 2022
From Benzinga
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
From Benzinga
Amgen’s new cancer drug faces questions about competition
September 15, 2022
From MarketWatch
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
From Benzinga
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.